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Ozone (O3) is a major smog-associated oxidant 
with well-established respiratory effects, includ-
ing decrements in lung function, airway injury 
and inflammation, compromised host defense, 
and asthma exacerbation (Hollingsworth et al. 
2007; Mudway and Kelly 2000). Although the 
lung has understandably been the target organ 
of interest, recent epidemiological evidence sug-
gests a positive association between inhaled O3 
and clinical cardiovascular events linked to cor-
onary artery disease, myocardial infarction, and 
atherosclerosis (Srebot et al. 2009); these effects 
are largely independent of exposure to other 
pollutants. In controlled human exposure stud-
ies, O3 exposure has reduced maximal oxygen 
uptake (Gong et al. 1998) and, in combination 
with ambient particulate matter (PM), increased 
diastolic blood pressure (Fakhri et al. 2009) and 
caused arterial vasoconstriction (Brook et al. 
2002). Adverse cardiovascular effects, including 
increased atherosclerotic plaque size (Chuang 
et al. 2009) and enhanced sensitivity to isch-
emic injury (Perepu et al. 2010), have also been 
reported in animal models.
Upon inhalation, O3 is thought to oxidate 
or peroxidate biological molecules (directly or 
indirectly) at the surface of the respiratory tract, 
triggering a pathological cascade characterized 
by lipid peroxidation, enzyme inactivation, 
free radical formation, altered membrane per-
meability, and inflammation (Mustafa 1990). 
Less is known, however, about the mechanisms 
mediating O3-induced cardiovascular responses 
and the potential influence of O3-induced 
respiratory effects on cardiovascular function. 
Although preliminary, the available evidence 
implicates the following mechanisms: vascular 
oxidative stress, endothelial/vascular dysfunc-
tion, inflammation, and altered autonomic 
tone (Srebot et al. 2009).
Because cardiac impulse formation, propa-
gation, and arrhythmia often result from the 
modulation of autonomic balance, one of the 
most conspicuous data gaps in the impact of O3 
exposure on normal cardiac electrophysiology 
and heart rate (HR) is the potential contribu-
tion of O3-induced modulation of autonomic 
tone to these effects. Additionally, O3 expo-
sure at ambient concentrations may not cause 
overt functional effects, but rather may pro-
duce latent or subclinical effects that appear 
only when the myocardium or specialized 
conduction system is further stressed, for 
example, as a result of cellular calcium load-
ing with aconitine. It is uncertain whether O3 
exposure elicits such effects. We have previ-
ously shown that exposure to PM (Carll et al. 
2011; Farraj et al. 2009, 2011; Hazari et al. 
2009), diesel exhaust (Hazari et al. 2011), or 
the irritant acrolein (Hazari et al. 2009) in 
hypertensive or heart failure rats causes func-
tional cardiac effects, including bradycardia, 
arrhythmia, increased parasympathetic tone, 
and/or increased sensitivity to triggered cardiac 
arrhythmia. The purpose of this study was to 
examine the concentration-dependent effects 
of acute O3 exposure on HR, heart rhythm, 
HR variability (HRV; a measure of autonomic 
tone to the heart), electrocardiography (ECG), 
and pulmonary and systemic inflammation. 
In addition, we assessed whether O3 exposure 
increases latent vulnerability to cardiac arrhyth-
mia, hypothesizing that O3 acts through the 
autonomic nervous system to prime the heart 
to react to secondary challenges.
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Ba c k g r o u n d: Ozone (O3) is a well-documented respiratory oxidant, but increasing   epidemiological 
evidence points to extrapulmonary effects, including positive associations between ambient O3 con-
centrations and cardiovascular morbidity and mortality. 
oB j e c t i v e: With preliminary reports linking O3 exposure with changes in heart rate (HR), we inves-
tigated the hypothesis that a single inhalation exposure to O3 will cause concentration-dependent 
autonomic modulation of cardiac function in rats. 
Me t h o d s : Rats implanted with telemeters to monitor HR and cardiac electro  physiology [electro-
cardiography (ECG)] were exposed once by whole-body inhalation for 4 hr to 0.2 or 0.8 ppm O3 
or filtered air. A separate cohort was tested for vulnerability to aconitine-induced arrhythmia 24 hr 
after exposure. 
re s u l t s: Exposure to 0.8 ppm O3 caused bradycardia, PR prolongation, ST depression, and sub-
stantial increases in atrial premature beats, sinoatrial block, and atrioventricular block, accompa-
nied by concurrent increases in several HR variability parameters that were suggestive of increased 
parasympathetic tone. Low-O3 exposure failed to elicit any overt changes in autonomic tone, heart 
rhythm, or ECG. However, both 0.2 and 0.8 ppm O3 increased sensitivity to aconitine-induced 
arrhythmia formation, suggesting a latent O3-induced alteration in myocardial excitability. 
co n c l u s i o n s: O3 exposure causes several alterations in cardiac electrophysiology that are likely 
mediated by modulation of autonomic input to the heart. Moreover, exposure to low O3 concentra-
tions may cause subclinical effects that manifest only when triggered by a stressor, suggesting that 
the adverse health effects of ambient levels of air pollutants may be insidious and potentially under-
estimated.
key w o r d s : air pollution, arrhythmia, autonomic, cardiac, electrocardiogram, heart rate variability, 
inhalation, latent, overt, ozone, rats. Environ Health Perspect 120:348–354 (2012).  http://dx.doi.
org/10.1289/ehp.1104244 [Online 2 December 2011]Overt and latent cardiac effects of O3
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Materials and Methods
Animals. Twelve-week-old male spontaneously 
hypertensive (SH) rats were obtained from 
Charles River Laboratory (Raleigh, NC). 
SH rats were selected because we previously 
determined (Farraj et al. 2009) that they 
are more sensitive to the inflammatory and 
proarrhythmic effects of acute air pollutant 
exposure [SH rats have higher mean arterial 
pressure (~ 40 mmHg difference), on average, 
than do control rats with normal blood 
pressure at 12 weeks of age (El-Mas and Abdel-
Rahman 2005)]. Rats were housed in plastic 
cages (one per cage), maintained on a 12/12-hr 
light/dark cycle at approximately 22°C and 
50% relative humidity in our Association for 
Assessment and Accreditation of Laboratory 
Animal Care–approved facility, and held for a 
minimum of 1 week before implantation. All 
protocols were approved by the Institutional 
Animal Care and Use Committee of the U.S. 
Environmental Protection Agency (EPA). Rat 
food (Prolab RMH 3000; PMI Nutrition 
International, St. Louis, MO) and water were 
provided ad libitum. All rats were randomized 
by weight. Animals were treated humanely 
and with regard for alleviation of suffering.
Experimental design and O3 exposure. 
SH rats were surgically implanted with ECG 
biopotential telemeters and then exposed via 
whole-body inhalation to 0.2 or 0.8 ppm O3 
or filtered air once for 4 hr. ECG, HR, body 
temperature, and activity were monitored 
before, during, and after exposure to O3 or air. 
All telemetered rats were sacrificed 1 day after 
exposure to O3 or air. A second cohort of rats 
(untelemetered) in each exposure group was 
sacrificed 1 hr after exposure to assess potential 
immediate inflammatory or toxicity responses. 
A third cohort of rats in each exposure group 
was challenged with aconitine to assess sen-
sitivity to arrhythmogenic challenge. O3 was 
generated by passing extra dry oxygen past 
an arcing transformer in a model V5-0 ozone 
generator (Ozone Research & Equipment 
Corp., Phoenix, AZ). The chamber concen-
trations (0.2 and 0.8 ppm) were controlled 
by the computer program DASYLab (version 
9.0; DasyTec USA, Amherst, NH), which 
controlled the opening and closing of a mass 
flow controller at each chamber. The actual 
concentration was then read by an O3 analyzer 
(model 400; Teledyne-Advanced Pollution 
Instruments, Inc., Thousand Oaks, CA), 
which fed a signal to a proportional, integral, 
derivative loop control, which then either 
opened or closed the mass flow controller to 
maintain the O3 concentration in the cham-
ber at the desired level. Rats were acclimated 
to the whole-body chamber for 1 hr/day for 
2 days before exposure to O3 or filtered air.
Surgical implantation of telemeters. 
Animals (n = 6/group) were anesthetized 
with an intraperitoneal (ip) injection of 
1 mL/kg of 80 mg/mL ketamine hydrochlo-
ride, 12 mg/mL xylazine hydrochloride solu-
tion (Sigma Chemical Co., St. Louis, MO). 
The anesthetized rats were implanted with a 
biopotential radiotelemetry transmitter (model 
TA11CTA-F40; Data Sciences International, 
Inc., St. Paul, MN) using aseptic surgical proce-
dures as previously described (Farraj et al. 2009) 
to obtain an ECG signal similar to that derived 
from lead II from the standard ECG and to 
allow measurement of core body temperature. 
The animals were allowed 2 weeks for recovery 
from surgery before exposure to O3 or air.
Radiotelemetry data acquisition and 
analysis. Radiotelemetry allowed continu-
ous monitoring and collection of ECG data 
(acquired using Data ART3.01 acquisition 
software; Data Sciences International, Inc., 
St. Paul, MN) in unanesthetized rats from 
the time of implantation of the transmit-
ters until sacrifice. Receivers (model RPC-1; 
Data Sciences International, Inc.) were posi-
tioned underneath home cages or in whole-
body exposure chambers during exposure. 
Sixty-second segments of ECG waveforms 
were acquired from animals in their home 
cages and saved at 15-min intervals from the 
time of surgical recovery through euthanasia. 
Values were obtained sequentially by animal 
and represent averages of 60 sec of data per 
animal for each 15-min period. HR was auto-
matically obtained from the ECG waveform 
with data acquisition software. Preexposure 
data permitted each animal to serve as its own 
control, and animals exposed to air provided 
time-paired control data. Preexposure baseline 
data were obtained while the rats were in the 
whole-body chamber just before the begin-
ning of exposure, collected in 120-sec periods 
once every 5 min for 1 hr. Whole-body inha-
lation exposure data were collected in 120-
sec periods once every 5 min for the duration 
of the 4-hr exposure period. The rats were 
then returned to their home cages, and post-
exposure data (60 sec of data every 15 min) 
were collected until euthanasia, approximately 
18 hr after the end of exposure.
ECG, arrhythmia identification, and HRV 
ecgAUTO software (version 2.5.1.35; EMKA 
Technologies USA, Falls Church, VA) was 
used for automated analysis of ECG wave 
amplitudes and segment durations and areas, as 
well as visual identification and enumeration of 
cardiac arrhythmias, and arrhythmia analysis. 
The following parameters were determined 
for each ECG waveform: PR interval; QRS 
duration, amplitude, and area; QT interval; 
HR-corrected QT interval (QTc; Bazett’s 
formula); ST interval, amplitude, and area; 
R-wave amplitude and interval; and T-wave 
amplitude and area. To account for potential 
effects of normal circadian rhythm, ECG 
parameters were quantified over four 6-hr 
periods for time-matched comparisons between 
preexposure and postexposure periods while the 
rats were unrestrained in their home cages. The 
times analyzed were 0000 hours to 0600 hours, 
0600 hours to 1200 hours, 1200 hours to 1800 
hours, and 1800 hours to 0000 hours. ECG 
parameters during exposure were analyzed as 
baseline (120 sec of data collected every 5 min 
for 1 hr while in the whole-body chamber 
immediately before the beginning of exposure) 
and hours 0–4 during exposure (120 sec of 
data collected every 5 min for 4 hr while in 
the whole-body chamber during exposure 
constituting the entire exposure period between 
~ 0830 hours and 1230 hours).
Cardiac arrhythmic events were identi-
fied in part by using the Lambeth conventions 
(Walker et al. 1988) as a guideline for the iden-
tification of arrhythmias in rats. Arrhythmias 
were identified as atrial premature beats 
(APBs), ventricular premature beats, sinoatrial 
blocks (SABs), atrioventricular blocks (AVBs), 
or ventricular tachycardia. Arrhythmias were 
quantified and totaled over an 18-hr period 
before exposure (this corresponded to the same 
times assessed after exposure), during the 4-hr 
exposure period, and during the 18-hr period 
beginning immediately after exposure. Total 
arrhythmia counts during exposure were quan-
tified (in a total of 48 two-minute segments 
during the 4-hr exposure period). To arrive 
at counts per hour, the total amount of time 
sampled in minutes (96) was divided by the 
number of minutes per hour (60).
HRV is the degree of difference in the 
interbeat intervals of successive heartbeats 
and is an indicator of the balance between 
the sympathetic and parasympathetic arms 
of the autonomic nervous system (Rowan 
et al. 2007). Low HRV, reflecting increased 
sympathetic tone (Rowan et al. 2007), is 
associated with increased cardiovascular 
morbidity and mortality (Bigger et al. 1993; 
Corey et al. 2006). For HRV analysis, thor-
ough visual inspection was conducted to 
identify and exclude arrhythmias, artifacts, 
and sample periods with < 30 sec of distin-
guishable R-waves. HRV analysis generated 
HR and time-domain measures, including 
mean time between adjacent QRS-complex 
peaks (RR interval), standard deviation of the 
time between normal-to-normal (RR) beats 
(SDNN), SDNN normalized for the effects 
of HR [SDNN/(RR interval × 100)], root 
mean square of successive differences in adja-
cent RR intervals (RMSSD), and percentage 
of adjacent normal RR intervals differing by 
≥ 15 msec (pNN15). pNN15 is a measure of 
parasympathetic tone comparable to pNN50 
in humans. SDNN represents overall HRV, 
whereas RMSSD represents parasympathetic 
influence over HR (Rowan et al. 2007). HRV 
analysis also calculated frequency domain 
parameters, particularly low frequency (LF), 
high frequency (HF), and the ratio of these Farraj et al.
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two frequency domains (LF:HF). LF is gen-
erally believed to represent a combination 
of sympathetic and parasympathetic tone, 
whereas HF indicates parasympathetic tone, 
and LF:HF serves as an index of sympatho-
vagal balance (Rowan et al. 2007).
Necropsy, blood collection, and lung lavage. 
Rats were deeply anesthetized with an ip injec-
tion of Euthasol (200 mg/kg sodium pento-
barbital, 25 mg/kg phenytoin; Virbac Animal 
Health, Ft. Worth, TX) approximately 1 or 
18 hr after the end of exposure. Blood samples 
were collected from the abdominal aorta. The 
trachea was cannulated, and the right lung 
(except for the caudal lobe) was lavaged with a 
total volume of 20 mL/kg Ca2+/Mg2+/phenol 
red–free Dulbecco’s phosphate-buffered saline 
(SAFC Biosciences, Lenexa, MD) divided 
into two equal aliquots. The caudal lobe was 
collected for RNA analysis. Cytospins and 
cells differentials on lavaged cell samples 
(neutrophils, lymphocytes, macrophages, and 
eosinophils per millimeter of bronchoalveo-
lar lavage fluid) and assays for total protein 
(Thermo Fisher Diagnostics, Rockford, IL); 
albumin (DiaSorin, Stillwater, MN); lactate 
dehydrogenase (Thermo DMA, Louisville, 
CO); N-acetyl-β-d-glucosaminidase (Roche 
Diagnostics, Mannheim, Germany); super-
oxide dismutase (Randox Laboratories Ltd., 
Crumlin, CO); glutathione peroxidase and 
glutathione S-transferase [based on an in-
house automated analysis (Jaskot et al. 1983)], 
serum C-reactive protein (DiaSorin); creatine 
kinase (Fisher Diagnostics, Middletown, VA); 
sorbitol dehydrogenase (Sekisui Diagnostics, 
Charlottetown, Canada); creatinine (Sekisui 
Diagnostics); high-density lipoprotein cho-
lesterol (HDL), low-density lipoprotein 
(LDL) cholesterol, and plasma angiotensin-
  converting enzyme (Fisher Diagnostics); and 
fibrinogen (DiaSorin) in lavage supernatants 
were conducted as previously described (Farraj 
et al. 2009).
Hearts were weighed and normalized 
by body weight before necropsy to examine 
effects of exposure on heart mass.
Aconitine challenge. Eighteen hours after 
exposure to O3, a separate cohort of animals 
were anesthetized with urethane (1.5 g/kg, 
ip; Sigma Chemical Co.) and underwent the 
aconitine challenge; supplemental doses of the 
anesthetic were administered intravenously 
(i.v.) when necessary to abolish pain reflex. 
Animal body temperature was maintained at 
approximately 36°C with a heating pad. The 
left jugular vein was cannulated with PE-50 
polyethylene tubing for the administration of 
aconitine. Aconitine (10 μg/mL) was continu-
ously infused at a speed of 0.2 mL/min, and 
ECG activity was continuously monitored and 
timed. Sensitivity to arrhythmia was measured 
as the threshold dose of aconitine required to 
produce ventricular premature beats, ventricu-
lar tachycardia, ventricular fibrillation, and 
cardiac arrest:
Threshold dose (μg/kg) for arrhythmia = 
10 μg/mL × 0.2 mL/min  
× time required for inducing arrhythmia (min) 
÷ body weight (kg)    [1]
Statistics. The statistical analyses for all 
data in this study were performed using SAS 
software (version 9.2; SAS Institute Inc., Cary, 
NC). PROC MIXED procedure was used 
to analyze the ECG, HR, and HRV data. A 
linear mixed model with restricted maximum-
likelihood estimation analysis (SAS) and least 
squares means post hoc test were used to 
determine statistical differences for all data. All 
the biochemical and cell differential data were 
analyzed using analysis of variance (ANOVA) 
examining the main effects of each model as 
well as the interactive effects. p-Values < 0.05 
were considered statistically significant. 
Pairwise comparisons were performed as an 
ANOVA subtest, adjusting the significance 
level for multiple comparisons using Tukey’s 
post hoc test. A correlation analysis between 
Figure 1. HR (A), PR interval (B), QTc (C), and ST area (D) immediately before (baseline) and during (expo-
sure) 4-hr exposure to 0.2 ppm or 0.8 ppm O3 or filtered air (mean ± SE, n = 6). 
*Significantly less than preexposure baseline values within corresponding group (p < 0.05). **Significantly greater than 
preexposure baseline values within corresponding group (p < 0.05). 
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pairs of variables during exposure was carried 
out using the Pearson product-moment cor-
relation coefficient (r).
Results
HR and ECG morphology. High-O3 exposure 
caused a significant decrease in HR (22.1%; 
p < 0.05) relative to preexposure baseline val-
ues (Figure 1). There was no significant effect 
of low-O3 or air exposure on HR.
Also relative to corresponding pre  exposure 
baseline values, high-O3 exposure caused a 
significant increase in PR interval (20.3%; 
p < 0.05), a significant decrease in QTc 
(7.9%; p < 0.05), and a significant increase in 
negative ST area (25%; p < 0.05) (Figure 1). 
High-O3 exposure also caused a significant 
increase in RR interval (26.7%; p < 0.05; 
Figure 2). There were no significant effects in 
any of these parameters in the low-O3 or air-
exposed groups.
There were no significant postexposure 
effects in any ECG interval and contour 
parameters in any groups (data not shown).
Arrhythmia. High-O3 exposure caused 
a significant increase in the number of 
APBs (2,200%; p < 0.05), SABs (32,600%; 
p < 0.05), and Mobitz type I second-degree 
AVBs (1,300%; p < 0.05) during expo-
sure rela  tive to preexposure baseline values 
(Table 1). There was no significant effect 
of low-O3 or air exposure on any measured 
arrhythmia. There were little to no significant 
postexposure effects in arrhythmia number in 
any groups (data not shown).
HRV parameters. High-O3 exposure 
caused a significant increase in SDNN (119%; 
p < 0.05; Figure 2), RMSSD (485%; p < 0.05; 
Figure 2), LF (7,070%; p < 0.05; data not 
shown), HF (1,900%; p < 0.05; Figure 2), 
and LF:HF (137%; p < 0.05; data not shown) 
relative to preexposure baseline values. There 
was no significant effect of low-O3 or air 
exposure on any measured HRV parameter. 
There were no significant postexposure effects 
on HR or any HRV parameters in any of the 
exposure groups (data not shown).
There were significant correlations between 
high-O3–induced increases in SDNN and 
several time-matched ECG parameters and 
arrhythmia (Figure 3). SDNN positively 
correlated with RR (r = 0.920; p < 0.001; 
Figure 3) and PR (r = 0.729; p < 0.001; 
Figure 3) intervals and SAB (r = 0.685; 
p < 0.001; Figure 3) and negatively correlated 
with ST area (r = –0.541; p < 0.001; Figure 3) 
and QTc (r = –0.806; p < 0.001; data not 
shown). A correlation between SDNN and 
APB barely fell below the threshold of sig-
nificance (r = 0.280; p = 0.054; data not 
shown). SDNN significantly correlated with 
PR prolongation with exposure to low O3 
(r = –0.326; p < 0.001; data not shown) and 
air (r = 0.404; p < 0.001; data not shown). 
There were no other significant correlations 
with SDNN in any of the remaining param-
eters in the low-O3–exposed and air-exposed 
groups (data not shown).
Temperature and heart weight. High-O3 
exposure caused a significant decrease in 
core body temperature [see Supplemental 
Material, Table 1 (http://dx.doi.org/10.1289/
ehp.1104244)]. There were no significant 
effects of low O3 or air on core body tempera-
ture. There were no significant effects of expo-
sure on heart weight (data not shown).
Indicators of inflammation in lung and 
serum. With few exceptions, O3 exposure at 
both concentrations had no statistically signifi-
cant effect on indicators of inflammation and 
injury in lung lavage, serum, and plasma at 
either 1 or 18 hr after O3 exposure. High O3 
did cause a significant decrease in serum HDL 
(mean ± SE: air, 34.9 ± 7.2 mg/dL; 0.8 ppm 
O3, 17.2 ± 0.7 mg/dL; 51%; p < 0.05) and 
creatinine (air, 0.62 ± 0.03 mg/dL; 0.8 ppm 
O3, 0.43 ± 0.03 mg/dL; 31%; p < 0.05) 
and a significant increase in serum sorbitol 
dehydrogenase (air, 14.1 ± 2.6 U/L; 0.8 ppm 
O3, 30.9 ± 6.4 U/L; 119%; p < 0.05) rela-
tive to air controls 24 hr after exposure. High 
O3 caused a small increase (62% relative to 
air group) in lung lavage neutrophils 18 hr 
after exposure that was not statistically signifi-
cant [Supplemental Materials, Table 2 (http://
dx.doi.org/10.1289/ehp.1104244)].
Sensitivity to aconitine. Eighteen hours 
after O3 exposure, both low- and high-O3 
exposure significantly reduced the total dose 
of aconitine necessary to elicit the first ven-
tricular premature beat relative to air-exposed 
controls (28% and 39%, respectively; p < 0.05; 
Figure 4). Both low and high O3 also sig-
nificantly reduced the total dose of aconitine 
necessary to elicit the first episode of ventric-
ular tachycardia relative to air-exposed con-
trols (26% and 42%, respectively; p < 0.05). 
Only the high O3 concentration significantly 
reduced the total dose of aconitine necessary to 
elicit the first episode of ventricular fibrillation 
and cardiac arrest relative to air-exposed con-
trols (30% and 39%, respectively; p < 0.05).
Table 1. Number of arrhythmias per hour immediately before and during the 4-hr exposure period 
(mean ± SE).
Exposure
Arrhythmia
APB SAB AVB
Baseline Exposure Baseline Exposure Baseline Exposure
Air 0.5 ± 0.8 0.2 ± 0.2 1 ± 1 0.1 ± 0.2 0 ± 0 0.2 ± 0.2
0.2 ppm O3 3.5 ± 3.5 1.1 ± 0.4 1 ± 1 0.2 ± 0.3 0 ± 0 0 ± 0
0.8 ppm O3 1.0 ± 1.0 23 ± 14* 1 ± 1 327 ± 99* 0 ± 0 14 ± 7*
*Significantly greater than corresponding preexposure baseline value (p < 0.05).
Figure 3. Pearson product-moment correlation analysis between SDNN and RR (A), PR interval (B), 
SAB (C), and ST area (D) during exposure to 0.8 ppm O3. Simple regression lines are superimposed on 
each figure. The Pearson product-moment correlation coefficient (r) is indicated for each relationship. 
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Discussion
We found that inhalation of O3 for a brief 
period causes concentration-dependent overt 
and latent neurophysiological and electro-
physio  logical effects in SH rats, a strain of 
rat known to demonstrate cardiac effects in 
response to inhaled ambient PM, diesel exhaust 
particles, and acrolein (Farraj et al. 2009, 2011; 
Hazari et al. 2011). Among the most strik-
ing effects with high (0.8 ppm) but not low 
(0.2 ppm) O3 were ECG alterations that were 
suggestive of changes in repolarization (ST 
depression and QT shortening) and atrioven-
tricular conduction block (PR prolongation). 
Only the high-O3 exposure caused significant 
ST depression. Although rats lack an equiva-
lent human ST segment because of the rapidity 
with which their ventricular myocytes repolar-
ize, perturbations that result in ST segment 
changes in species with ST segments produce 
a similar shift in the corresponding QRS-T 
wave region of the ECG in rats (Detweiler 
1981). ST segment depression in humans is 
temporally associated with myocardial isch-
emia (Detweiler 1981) and has been associated 
with exposure to other air pollutants, including 
PM (Pekkanen et al. 2002). Although the ST 
segment changes are suggestive of ischemia, 
measure  ments of biological indicators of isch-
emia were not performed in this study and 
will be needed to confirm ischemia in future 
studies. High-O3 exposure also caused QT 
shortening, but the significance of this finding 
is unclear. Moreover, high-O3 exposure pro-
longed the PR interval, providing evidence of 
slowing between atrial and ventricular activa-
tion. Uchiyama et al. (1986) reported similar 
findings with 1 ppm O3 in rats. PR prolonga-
tion is usually associated with increased para-
sympathetic tone (Sapire et al. 1979).
High- but not low-O3 exposure increased 
episodes of APBs, SAB, and second-degree 
Mobitz type I AVB arrhythmias, consistent 
with the proarrhythmic effects of O3 described 
in several epidemiological studies (e.g., Chiu 
and Yang 2009; Sarnat et al. 2006). APBs 
are ectopic beats that originate within the 
atria and have been linked to increased para-
sympathetic tone (Wilhelm et al. 2011). These 
findings are consistent with those reported 
by Uchiyama et al. (1986), where O3 expo-
sure caused increased APBs and AVBs in rats. 
Furthermore, this is the first study to report 
an increase in SAB with O3 exposure in 
an experimental model. SAB in humans is 
believed to be caused by a block of conduc-
tion within the sinoatrial junction while the 
sinus node itself functions normally (Chung 
1983). High-O3 exposure also increased AVB, 
which in humans is characterized by the fail-
ure of some atrial impulses to be conducted 
to the ventricles (Chung 1983). Both SAB 
and AVB have also been linked with increased 
para  sympathetic tone (Page et al. 1991). The 
exact sites of the blocks produced in the pres-
ent study are not known and could have been 
obtained with only intracardiac recordings, 
which were beyond the scope of this study. 
Although it is unclear whether such anatomi-
cal lesions exist in rats and what, if any, trans-
lational clinical significance they have, these 
findings point to an increased proclivity to the 
development of arrhythmias with O3 exposure. 
The predisposition of susceptible individuals to 
the development of cardiac arrhythmias after 
O3 exposure and the mechanisms mediating 
these responses need to be further studied.
Only rats exposed to high O3 had a sig-
nificant decrease in HR and a significant 
increase in multiple HRV parameters, includ-
ing SDNN, RMSSD, and HF, all of which 
indicate a shift toward increased parasympa-
thetic tone. High-O3 exposure also caused an 
increase in LF and LF:HF. LF, however, is a 
poor indicator of sympathetic tone, particularly 
in heart failure patients (Notarius et al. 1999), 
and instead may reflect an interaction of the 
sympathetic and parasympathetic nervous sys-
tems (Houle and Billman 1999). Multiple 
reports using experimental models indicate 
similar decreases in HR with O3 exposure 
(e.g., Uchiyama et al. 1986; Watkinson et al. 
2001). Moreover, Peel et al. (2011) found 
that O3 exposure is associated with increased 
occurrence of apnea and bradycardia in high-
risk infants, suggesting similarly elevated para-
sympathetic tone, and Davoodi et al. (2010) 
demonstrated that air-pollution–induced 
increases in arrhythmias were linked with 
increased RMSSD. Analogous findings have 
been reported in experimental models, includ-
ing cholinesterase inhibition after O3 exposure 
in guinea pigs (exaggerates parasympathetic 
activity; Gordon et al. 1981), reversal of 
O3-induced bradycardia with atropine in rats 
(parasympathetic blocker; Arito et al. 1992), 
and vagotomy in dogs (Vaughan et al. 1971). 
These findings contrast with recent epidemio-
logical studies pointing to decreased HRV and 
increased sympathetic tone with O3 exposure 
(Schwartz et al. 2005; Zanobetti et al. 2010). 
The disparity in effects may be explained by 
the timing of assessments because, as we have 
previously demonstrated, rats transition from 
elevated parasympathetic tone during exposure 
to air pollutants (Farraj et al. 2011) to sympa-
thetic mediation of cardiac effects 1 day after 
exposure (Hazari et al. 2011). Nevertheless, 
increased HRV may also have links to adverse 
health outcomes. For example, Farkas et al. 
(2008) showed that increased parasympathetic 
tone is a precursor to drug-induced torsade de 
pointes (a precursor arrhythmia to ventricular 
fibrillation; Gralinski 2003) and is associated 
with increased apnea severity in obese patients 
(Reynolds et al. 2007), adverse cardio  vascular 
events in type II diabetics (Eguchi et al. 
2010), and increased mortality in heart failure 
(Stein et al. 2005). The relationship between 
increased parasympathetic tone, O3 exposure, 
and cardiac dysfunction requires further study.
The concurrence of HRV, ECG, and 
arrhythmia changes during exposure cou-
pled with their strongly significant correla-
tion suggests a potential interdependence. 
O3-exposure–induced increases in SDNN 
positively correlated with PR prolongation and 
increased SAB and negatively correlated with 
HR, QTc, and ST area. Although not proving 
a direct cause–effect relationship, these find-
ings suggest that increased parasympathetic 
tone may have played a role in the contempo-
raneous induction of several ECG anomalies. 
The rapid onset of these responses suggests 
triggering by sensory irritation originating in 
the nose or lung. The activation of irritant 
nerve fibers, including pulmonary C-fibers, 
by air pollutants elicits a reflex cardiopulmo-
nary response characterized by apnea, bron-
chospasm, hypotension, and bradycardia 
(Widdicombe and Lee 2001). Although Jimba 
et al. (1995) showed that O3 does not acti-
vate transient receptor potential (TRP) chan-
nel V1-expressing C-fibers, Taylor-Clark and 
Undem (2010) recently demonstrated that O3 
exposure activates TRPA1-expressing airway 
C-fibers. Moreover, our group has shown that 
increases in sensitivity to aconitine-induced 
Figure 4. Cumulative dose of infused aconitine necessary to trigger ventricular premature beats (VPB), 
ventricular tachycardia (VT), ventricular fibrillation (VF), and cardiac arrest (CA) in rats approximately 18 hr 
after a single exposure to 0.2 ppm or 0.8 ppm O3 or filtered air (mean ± SE, n = 5). 
*Significantly less than air control for corresponding arrhythmia (p < 0.05).
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arrhythmia after diesel exhaust exposure is 
dependent on the activation of TRPA1 on air-
way sensory nerves (Hazari et al. 2011). Thus, 
the enhanced sensitivity to O3 in this study 
may also have been driven by activation of the 
TRPA1 receptor; future studies will be needed 
to confirm this. 
The impact of the small changes in lung 
neutrophils, serum HDL cholesterol, crea-
tinine, and sorbitol dehydrogenase on the 
observed cardiac responses is unclear. The 
absence of significant cellular inflamma-
tion and oxidative changes, however, sug-
gests that these phenomena played little to 
no role in the elicitation of these cardiac 
responses. High O3 also caused a 3°C drop 
in core body temperature during exposure; 
such drops in body temperature are believed 
to be part of a hypothermic response to toxi-
cants unique to rodents that serves to protect 
the animal from further injury (Gordon et al. 
1988; Watkinson et al. 1997). Brady  cardia, 
brady  arrhythmias, and PR prolongation have 
all, however, been associated with reduced 
internal body temperature in humans, par-
ticularly in hypothermia (de Souza et al. 
2007). Further work is required to determine 
whether temperature changes play any role in 
eliciting such cardiac effects.
A striking outcome of both high- and 
low-O3 exposure was an increased sensitivity 
to cardiac arrhythmia triggered 1 day after 
exposure, indicating latent/indirect con-
sequences of a single exposure to this oxi-
dant air pollutant. Aconitine, a cardiotoxic 
alkaloid used commonly to induce experi-
mental arrhythmia, suppresses inactivation 
of   tetrodotoxin-sensitive sodium channels in 
the myocardium and other excitable tissues 
(Hazari et al. 2009). Increased sensitivity to 
aconitine suggests that O3 exposure altered the 
degree to which the cardiovascular system can 
withstand stress by lowering the threshold for 
the initiation of adverse ventricular arrhyth-
mias. These results are similar to our previous 
findings with particulate and gaseous pollut-
ants (Hazari et al. 2009, 2011) suggesting that 
air pollutant exposure increases the sensitivity 
of the cardiac electrical conduction system 
in a nonspecific fashion. The exact nature of 
this alteration is unclear. One plausible pos-
sibility is slowing of the ventricular activation 
rate secondary to increased parasympathetic 
influence, with attendant intracellular calcium 
loading (Shattock and Bers 1989) and super-
imposed increased fast sodium current. These 
phenomena may have caused sarcoplasmic 
reticular overload, leading to spontaneous cal-
cium release and triggered activity (a mecha-
nism of arrhythmia formation). Moreover, 
ventricular remodeling may be a contributing 
factor because SH rats undergo changes in ion 
channel expression (Goltz et al. 2007) during 
progression of their hypertensive phenotype 
that may heighten myocardial sensitivity. 
Further work is required to confirm any myo-
cardial changes or other mechanisms that may 
account for this phenomenon. 
Perhaps most compelling is our finding that 
0.2 ppm O3 also increased sensitivity to aconi-
tine-triggered cardiac arrhythmia despite failing 
to elicit any direct overt cardiac alterations as 
were observed with exposure to 0.8 ppm O3. 
These findings indicate that exposure to low O3 
concentrations may cause subclinical/  insidious 
effects that manifest only when triggered by 
a stressor, suggesting that the health effects of 
ambient levels of air pollutants may be insidious 
and potentially underestimated.
Conclusion
O3 exposure caused HR and ECG changes that 
were accompanied by a shift in sympatho  vagal 
balance, but no apparent significant cellular 
inflammation, indicating potential mediation 
by increased parasympathetic tone and less 
dependence on the overt injury and inflamma-
tion common at high concentrations. Sensory/
irritant responses (e.g., pulmonary C-fiber acti-
vation) may have played a role in triggering 
these autonomic/ECG effects and should be 
examined in future studies. Perhaps of greater 
significance is the finding that O3 causes latent 
effects, suggesting that exposure would render a 
subject acutely sensitive to the effects of a non-
specific cardiac trigger. This presumably tran-
sient window of hypersensitivity is particularly 
worrisome in individuals with preexisting car-
diovascular disease who are already burdened 
by a reduced capacity for compensation. Thus, 
the wealth of knowledge we have on the direct 
effects of O3 may not fully inform us of the 
complex cardiopulmonary response profile of 
this oxidant. That this latent cardiac effect was 
present at concentrations that caused no overt 
toxicity [i.e., 0.2 ppm, approximately three 
times the U.S. EPA’s current O3 8-hr National 
Ambient Air Quality Standard of 0.075 ppm 
(U.S. EPA 2006)] is alarming and suggests that 
controlled human and experimental exposure 
studies may underestimate the effects of expo-
sure. Conversely, these findings are consistent 
with epidemiological studies that demonstrate 
adverse effects with relatively small spikes in 
ambient O3 concentrations (e.g., 10 ppb; Bell 
et al. 2004). Collectively, these findings pro-
vide new insight into the effects and mecha-
nisms of O3 and highlight the complexity of 
the assessment of the cardiovascular toxicity of 
different air sheds.
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